418 related articles for article (PubMed ID: 19741459)
1. Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras.
de Jager SC; Canté-Barrett K; Bot I; Husberg C; van Puijvelde GH; van Santbrink PJ; Yndestad A; van den Oever JM; Kuiper J; van Berkel TJ; Lipp M; Zwaginga JJ; Fibbe WE; Aukrust P; Biessen EA
Transplantation; 2009 Sep; 88(5):631-9. PubMed ID: 19741459
[TBL] [Abstract][Full Text] [Related]
2. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
3. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
5. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice.
Li A; Zhang Q; Jiang J; Yuan G; Feng Y; Hao J; Li C; Gao X; Wang G; Xie S
Gene Ther; 2006 Aug; 13(15):1178-87. PubMed ID: 16598299
[TBL] [Abstract][Full Text] [Related]
6. Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease.
Maeda Y; Tawara I; Teshima T; Liu C; Hashimoto D; Matsuoka K; Tanimoto M; Reddy P
Exp Hematol; 2007 Feb; 35(2):274-86. PubMed ID: 17258076
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.
Yakoub-Agha I; Saule P; Depil S; Grutzmacher C; Boulanger F; Magro L; Jouet JP; Dessaint JP; Labalette M
Exp Hematol; 2007 Jun; 35(6):861-71. PubMed ID: 17533040
[TBL] [Abstract][Full Text] [Related]
8. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
Brok HP; Vossen JM; Heidt PJ
Bone Marrow Transplant; 1997 Mar; 19(6):601-6. PubMed ID: 9085739
[TBL] [Abstract][Full Text] [Related]
10. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells.
Fukui J; Inaba M; Ueda Y; Miyake T; Hosaka N; Kwon AH; Sakaguchi Y; Tsuda M; Omae M; Kamiyama Y; Ikehara S
Stem Cells; 2007 Jun; 25(6):1595-601. PubMed ID: 17446564
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease.
Li H; Guo Z; Jiang X; Zhu H; Li X; Mao N
Stem Cells; 2008 Oct; 26(10):2531-41. PubMed ID: 18635870
[TBL] [Abstract][Full Text] [Related]
12. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK
Biol Blood Marrow Transplant; 2005 Mar; 11(3):169-80. PubMed ID: 15744235
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
[TBL] [Abstract][Full Text] [Related]
14. T-cell P/E-selectin ligand alpha(1,3)fucosylation is not required for graft-vs-host disease induction.
Eom HS; Rubio MT; Means TK; Luster AD; Sykes M
Exp Hematol; 2005 Dec; 33(12):1564-73. PubMed ID: 16338500
[TBL] [Abstract][Full Text] [Related]
15. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
Suzuki Y; Adachi Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Ikehara S
Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
[TBL] [Abstract][Full Text] [Related]
16. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
17. Significant MLR but not CTL responses against recipient antigens generated in T cells from bone marrow chimeras recovered from acute GVHD.
Morohashi T; Ogasawara K; Kitaichi N; Iwabuchi K; Onoé K
Bone Marrow Transplant; 2000 Nov; 26(10):1069-76. PubMed ID: 11108305
[TBL] [Abstract][Full Text] [Related]
18. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
[TBL] [Abstract][Full Text] [Related]
19. Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease.
Yang I; Weiss L; Abdul-Hai A; Kasir J; Reich S; Slavin S
Cancer Res; 2005 Nov; 65(21):9735-40. PubMed ID: 16266994
[TBL] [Abstract][Full Text] [Related]
20. [The influence of subclinical level of graft versus host reaction on reconstitution of host lymphoid tissues].
Hirano M
Hokkaido Igaku Zasshi; 1994 May; 69(3):453-65. PubMed ID: 7927174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]